Parasite neuropeptide biology: Seeding rational drug target selection?

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 76-91

  McVeigh, Paul ^a   Atkinson, Louise ^a   Marks, Nikki J ^a   Mousley, Angela ^a   Dalzell, Johnathan J ^a   Sluder, Ann ^b   Hammerland, Lance ^c   Maule, Aaron G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b SCYNEXIS Inc   (United States)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Anthelmintic; Nervous system; Neuromuscular; Receptor; Signalling

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTHELMINTIC AGENT; CARBOXYPEPTIDASE H; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NICOTINIC RECEPTOR; SERINE PROTEINASE; SIGNAL RECOGNITION PARTICLE;

AMIDATION; CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; DRUG TARGETING; ECHINOCOCCUS MULTILOCULARIS; ENDOPLASMIC RETICULUM; EXOCYTOSIS; MELOIDOGYNE INCOGNITA; MOLECULAR DOCKING; NONHUMAN; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROCESSING; REVIEW; RNA INTERFERENCE; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SECRETORY VESICLE; SIGNAL TRANSDUCTION;

EID: 84861468464     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2011.10.004     Document Type: Review

References (256)

1. Abad P., Gouzy J., Aury J.M., Castagnone-Sereno P., Danchin E.G., Deleury E., Perfus-Barbeoch L., Anthouard V., Artiguenave F., Blok V.C., Caillaud M.C., Coutinho P.M., Dasilva C., De Luca F., Deau F., Esquibet M., Flutre T., Goldstone J.V., Hamamouch N., Hewezi T., Jaillon O., Jubin C., Leonetti P., Magliano M., Maier T.R., Markov G.V., McVeigh P., Pesole G., Poulain J., Robinson-Rechavi M., Sallet E., Ségurens B., Steinbach D., Tytgat T., Ugarte E., van Ghelder C., Veronico P., Baum T.J., Blaxter M., Bleve-Zacheo T., Davis E.L., Ewbank J.J., Favery B., Grenier E., Henrissat B., Jones J.T., Laudet V., Maule A.G., Quesneville H., Rosso M.N., Schiex T., Smant G., Weissenbach J., Wincker P. Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita. Nat. Biotechnol. 2008, 26:909-915.
2. Ahier A., Khayath N., Vicogne J., Dissous C. Insulin receptors and glucose uptake in the human parasite Schistosoma mansoni. Parasite 2008, 15:573-579.
3. Arena J.P., Liu K.K., Paress P.S., Schaeffer J.M., Cully D.F. Expression of a glutamate-activated chloride current in Xenopus oocytes injected with Caenorhabditis elegans RNA: evidence for modulation by avermectin. Brain Res. Mol. Brain Res. 1992, 15:339-348.
4. Asada A., Orii H., Watanabe K., Tsubaki M. Planarian peptidylglycine-hydroxylating monooxygenase, a neuropeptide processing enzyme, colocalizes with cytochrome b561 along the central nervous system. FEBS J. 2005, 272:942-955.
5. Atchison W.D., Geary T.G., Manning B., VandeWaa E.A., Thompson D.P. Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle. Toxicol. Appl. Pharmacol. 1992, 112:133-143.
6. Atkinson L., McVeigh P., Kimber M.J., Marks N.J., Eipper B.A., Mains R.E., Day T.A., Maule A.G. A PAL for Schistosoma mansoni PHM. Mol. Biochem. Parasitol. 2010, 173:97-106.
7. Avery L. The genetics of feeding in Caenorhabditis elegans. Genetics 1993, 133:897-917.
8. Balklava Z., Pant S., Fares H., Grant B.D. Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic. Nat. Cell Biol. 2007, 9:1066-1073.
9. Bargmann C.I. Neurobiology of the Caenorhabditis elegans genome. Science 1998, 282:2028-2033.
10. Barkus R.V., Klyachko O., Horiuchi D., Dickson B.J., Saxton W.M. Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol. Biol. Cell 2008, 19:274-283.
11. Baron R.L. A carbamate insecticide: a case study of aldicarb. Environ. Health Perspect. 1994, 102:23-27.
12. Bascal Z.A., Cunningham J.M., Holden-Dye L., O'Shea M., Walker R.J. Characterisation of a putative nitric oxide synthase in the neuromuscular system of the parasitic nematode Ascaris suum. Parasitology 2001, 122:219-231.
13. Bastiani, C., Mendel, J., 2006. Heterotrimeric G proteins in C. elegans (October 13, 2006), WormBook, (Ed.), The C. elegans Research Community, WormBook. Doi: , http://www.wormbook.org.
14. Berriman M., Haas B.J., LoVerde P.T., Wilson R.A., Dillon G.P., Cerqueira G.C., Mashiyama S.T., Al-Lazikani B., Andrade L.F., Ashton P.D., Aslett M.A., Bartholomeu D.C., Blandin G., Caffrey C.R., Coghlan A., Coulson R., Day T.A., Delcher A., DeMarco R., Djikeng A., Eyre T., Gamble J.A., Ghedin E., Gu Y., Hertz-Fowler C., Hirai H., Hirai Y., Houston R., Ivens A., Johnston D.A., Lacerda D., Macedo C.D., McVeigh P., Ning Z., Oliveira G., Overington J.P., Parkhill J., Pertea M., Pierce R.J., Protasio A.V., Quail M.A., Rajandream M.A., Rogers J., Sajid M., Salzberg S.L., Stanke M., Tivey A.R., White O., Williams D.L., Wortman J., Wu W., Zamanian M., Zerlotini A., Fraser-Liggett C.M., Barrell B.G., El-Sayed N.M. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-360.
15. Blobel G., Dobberstein B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J. Cell Biol. 1975, 67:835-851.
16. Bolkenius F.N., Ganzhorn A.J. Peptidylglycine alpha-amidating mono-oxygenase: neuropeptide amidation as a target for drug design. Gen. Pharmacol. 1998, 31:655-659.
17. Bouchard C., Ribeiro P., Dubé F., Anctil M. A new G protein-coupled receptor from a primitive metazoan shows homology with vertebrate aminergic receptors and displays constitutive activity in mammalian cells. J. Neurochem. 2003, 86(5):1149-1161.
18. Boulin T., Gielen M., Richmond J.E., Williams D.C., Paoletti P., Bessereau J.L. Eight genes are required for functional reconstitution of the Caenorhabditis elegans levamisole-sensitive acetylcholine receptor. Proc. Natl. Acad. Sci. USA 2008, 105:18590-18595.
19. Boulin T., Fauvin A., Charvet C., Cortet J., Cabaret J., Bessereau J.L., Neveau C. Functional reconstitution of Haemonchus contortus acetylcholine receptors in Xenopus oocytes provides mechanistic insights into levamisole resistance. Br. J. Pharmacol. 2011, 164:1421-1432.
20. Bowman J.W., Winterrowd C.A., Friedman A.R., Thompson D.P., Klein R.D., Davis J.P., Maule A.G., Blair K.L., Geary T.G. Nitric oxide mediates the inhibitory effects of SDPNFLRFamide, a nematode FMRFamide-related neuropeptide, in Ascaris suum. J. Neurophysiol. 1995, 74:1880-1888.
21. Bowman J.W., Friedman A.R., Thompson D.P., Ichhpurani A.K., Kellman M.F., Marks N., Maule A.G., Geary T.G. Structure-activity relationships of KNEFIRFamide (AF1), a nematode FMRFamide-related peptide, on Ascaris suum muscle. Peptides 1996, 17:381-387.
22. Bowman J.W., Friedman A.R., Thompson D.P., Maule A.G., Alexander-Bowman S.J., Geary T.G. Structure-activity relationships of an inhibitory nematode FMRFamide-related peptide, SDPNFLRFamide (PF1), on Ascaris suum muscle. Int. J. Parasitol. 2002, 32:1765-1771.
23. Boyle J.P., Wu X.J., Shoemaker C.B., Yoshino T.P. Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts. Mol. Biochem. Parasitol. 2003, 128(2):205-215.
24. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
25. Byrne A.B., Weirauch M.T., Wong V., Koeva M., Dixon S.J., Stuart J.M., Roy P.J. A global analysis of genetic interactions in Caenorhabditis elegans. J. Biol. 2007, 6:8.
26. Caffrey C.R., Rohwer A., Oellien F., Marhöfer R.J., Braschi S., Oliveira G., McKerrow J.H., Selzer P.M. A comparative chemogenomics strategy to predict essential drug targets in the metazoan pathogen, Schistosoma mansoni. PLoS One 2009, 4:e4413.
27. Carre-Pierrat M., Baillie D., Johnsen R., Hyde R., Hart A., Granger L., Ségalat L. Characterization of the Caenorhabditis elegans G protein-coupled serotonin receptors. Invertebr. Neurosci. 2006, 6(4):189-205.
28. Ceron J., Rual J.F., Chandra A., Dupuy D., Vidal M., van den Heuvel S. Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity. BMC Dev. Biol. 2007, 7:30.
29. Chahdi A., Daeffler L., Gies J.P., Landry Y. Drugs interacting with G protein alpha subunits: selectivity and perspectives. Fundam. Clin. Pharmacol. 1998, 12:121-132.
30. Charlton W.L., Harel H.Y., Bakhetia M., Hibbard J.K., Atkinson H.J., McPherson M.J. Additive effects of plant expressed double-stranded RNAs on root-knot nematode development. Int. J. Parasitol. 2010, 40(7):855-864.
31. Chase D.L., Koelle M.R. Genetic analysis of RGS protein function in Caenorhabditis elegans. Methods Enzymol. 2004, 389:305-320.
32. Collins J.J., Hou X., Romanova E.V., Lambrus B.G., Miller C.M., Saberi A., Sweedler J.V., Newmark P.A. Genome-wide analyses reveal a role for peptide hormones in planarian germline development. PLoS Biol. 2010, 8:e1000509.
33. Cottrell G.A., Green K.A., Davies N.W. The neuropeptide Phe-Met-Arg-Phe-NH2 (FMRFamide) can activate a ligand-gated ion channel in Helix neurones. Pflugers Arch. 1990, 416:612-614.
34. Cowden C., Stretton A.O. Eight novel FMRFamide-like neuropeptides isolated from the nematode Ascaris suum. Peptides 1995, 16(3):491-500.
35. Dalzell J.J., McMaster S., Fleming C.C., Maule A.G. Short interfering RNA-mediated gene silencing in Globodera pallida and Meloidogyne incognita infective stage juveniles. Int. J. Parasitol. 2010, 40:91-100.
36. Dalzell J.J., McVeigh P., Warnock N.D., Mitreva M., Bird D.McK., Abad P., Fleming C.C., Day T.A., Mousley A., Marks N.J., Maule A.G. RNAi effector diversity in nematodes. PLoS Negl. Trop. Dis. 2011, 5(6):e1176.
37. Davis R.E., Stretton A.O. Structure-activity relationships of 18 endogenous neuropeptides on the motor nervous system of the nematode Ascaris suum. Peptides 2001, 22(1):7-23.
38. Day T.A., Maule A.G., Shaw C., Halton D.W., Moore S., Bennett J.L., Pax R.A. Platyhelminth FMRFamide-related peptides (FaRPs) contract Schistosoma mansoni (Trematoda: Digenea) muscle fibres in vitro. Parasitology 1994, 109:455-459.
39. Day T.A., Maule A.G., Shaw C., Pax R.A. Structure-activity relationships of FMRFamide-related peptides contracting Schistosoma mansoni muscle. Peptides 1997, 18(7):917-921.
40. Day T.A., Haithcock J., Kimber M., Maule A.G. Functional ryanodine receptor channels in flatworm muscle fibres. Parasitology 2000, 120(4):417-422.
41. Dessal A.L., Prades R., Giralt E., Smrcka A.V. Rational design of a selective covalent modifier of G protein βγ subunits. Mol. Pharmacol. 2008, 79:24-33.
42. Dessal A.L., Prades R., Giralt E., Smrcka A.V. Rational design of a selective covalent modifier of G protein βγ subunits. Mol. Pharmacol. 2011, 79(1):24-33.
43. Dlakic M. A new family of putative insulin receptor-like proteins in C. elegans. Curr. Biol. 2002, 12:R155-R157.
44. Duckert P., Brunak S., Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 2004, 17(1):107-112.
45. Ducray P., Gauvry N., Pautrat F., Goebel T., Fruechtel J., Desaules Y., Weber S.S., Bouvier J., Wagner T., Froelich O., Kaminsky R. Discovery of amino-acetonitrile derivatives, a new class of synthetic anthelmintic compounds. Bioorg. Med. Chem. Lett. 2008, 18:2935-2938.
46. Eipper B.A., Stoffers D.A., Mains R.E. The biosynthesis of neuropeptides: peptide alpha-amidation. Annu. Rev. Neurosci. 1992, 15:57-85.
47. Emanuelsson O., Brunak S., von Heijne G., Nielsen H. Locating proteins in the cell using Target P, Signal P and related tools. Nat. Protoc. 2007, 2:953-971.
48. 2+ signaling in the isolated Caenorhabditis elegans intestine: role of the inositol-1,4,5-trisphosphate receptor and phospholipases C beta and gamma. J. Gen. Physiol. 2005, 126:379-392.
49. Esposito G., Amoroso M.R., Bergamasco C., Di Schiavi E., Bazzicalupo P. The G protein regulators EGL-10 and EAT-16, the Giα GOA-1 and the G(q)α EGL-30 modulate the response of the C. elegans ASH polymodal nociceptive sensory neurons to repellents. BMC Biol. 2010, 8:138-151.
50. Fellowes R., Maule A.G., Marks N.J., Geary T.G., Thompson D.P., Shaw C., Halton D.W. Modulation of the motility of the vagina vera of Ascaras suumin vitro by FMRFamide-related peptides. Parasitology 1998, 116:277-287.
51. Ferkey D.M., Hyde R., Haspel G., Dionne H.M., Hess H.A., Suzuki H., Schafer W.R., Koelle M.R., Hart A.C. C. elegans G protein regulatorRGS-3 controls sensitivity to sensory stimuli. Neuron 2007, 53:39-52.
52. Fernandez A.G., Gunsalus K.C., Huang J., Chuang L.S., Ying N., Liang H.L., Tang C., Schetter A.J., Zegar C., Rual J.F., Hill D.E., Reinke V., Vidal M., Piano F. New genes with roles in the C. elegans embryo revealed using RNAi of ovary-enriched ORFeome clones. Genome Res. 2005, 15:250-259.
53. Fernández D., Pallarès I., Vendell J., Avilés F.X. Progress in metallocarboxypeptidases and their small molecular weight inhibitors. Biochimie 2010, 92:1484-1500.
54. Fitzpatrick J.M., Peak E., Perally S., Chalmers I.W., Barrett J., Yoshino T.P., Ivens A.C., Hoffmann K.F. Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses. PLoS Negl. Trop. Dis. 2009, 3(11):e543.
55. Flower D.R. Modelling G protein-coupled receptors for drug design. Biochim. Biophys. Acta 1999, 1422:207-234.
56. Frand A.R., Russel S., Ruvkun G. Functional genomic analysis of C. elegans molting. PLoS Biol. 2005, 3:e312.
57. Fraser A.G., Kamath R.S., Zipperlen P., Martinez-Campos M., Sohrmann M., Ahringer J.A. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 2000, 408:325-330.
58. Fredriksson R., Schiöth H.B. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol. Pharmacol. 2005, 67:1414-1425.
59. Fricker L.D. Neuropeptide-processing enzymes: applications for drug discovery. AAPS J. 2005, 7:E449-E455.
60. + channel. Pflugers Arch. 2006, 451:646-656.
61. Gaiser A.M., Brandt F., Richter K. The non-canonical Hop protein from Caenorhabditis elegans exerts essential functions and forms binary complexes with either Hsc70 or Hsp90. J. Mol. Biol. 2009, 391:621-634.
62. Geary T.G., Kubiak T.M. Neuropeptide G-protein-coupled receptors, their cognate ligands and behavior in Caenorhabditis elegans. Trends Pharmacol. Sci. 2005, 26(2):56-58.
63. Geary T.G., Klein R.D., Vanover L., Bowman J.W., Thompson D.P. The nervous systems of helminths as targets for drugs. J. Parasitol. 1992, 78:215-230.
64. Geary T.G., Bowman J.W., Friedman A.R., Maule A.G., Davis J.P., Winterrowd C.A., Klein R.D., Thompson D.P. The pharmacology of FMRFamide-related neuropeptides in nematodes: new opportunities for rational anthelmintic discovery?. Int. J. Parasitol. 1995, 25:1273-1280.
65. Geary T.G., Thompson D.P., Klein R.D. Mechanism-based screening: discovery of the next generation of anthelmintic depends upon more basic research. Int. J. Parasitol. 1999, 29:105-112.
66. Geary T.G., Conder G.A., Bishop B. The changing landscape of antiparasitic drug discovery for veterinary medicine. Trends Parasitol. 2004, 20:449-455.
67. Geary T.G., Woo K., McCarthy J.S., MacKenzie C.D., Horton J., Prichard R.K., de Silva N.R., Olliaro P.L., Lazdins-Helds J.K., Engels D.A., Bundy D.A. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
68. Geary T.G. Nonpeptide ligands for peptidergic G protein-coupled receptors. Adv. Exp. Med. Biol. 2010, 692:10-26.
69. Golubovic A., Kuhn A., Williamson M., Kalbacher H., Holstein T.W., Grimmelikhuizen C.J., Gründer S. A peptide-gated ion channel from the freshwater polyp Hydra. J. Biol. Chem. 2007, 282:35098-35103.
70. Gonczy P., Echeverri C., Oegema K., Coulson A.R., Jones S.J.M., Copley R.R., Duperon J., Oegema J., Brehm M., Cassin E., Hannak E., Kirkham M., Pichler S.C., Flohrs K., Goessen A., Leidel S., Alleaume A.M., Martin C., Ozlu N., Bork P., Hymann A.A. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 2000, 408:331-336.
71. Gort E.H., Van Haaften G., Verlaan I., Groot A.J., Plasterk R.H., Shvarts A., Suijkerbuijk K.P., van Laar T., van der Wall E., Raman V., van Diest P.J., Tijsterman M., Vooijs M. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 2008, 27:1501-1510.
72. Gracheva E.O., Burdina A.O., Touroutine D., Berthelot-Grosjean M., Parekh H., Richmond J.E. Tomosyn negatively regulates CAPS-dependent peptide release at Caenorhabditis elegans synapses. J. Neurosci. 2007, 27:10176-10184.
73. Gracheva E.O., Burdina A.O., Touroutine D., Berthelot-Grosjean M., Parekh H., Richmond J.E. Tomosynnegatively regulates both synaptic transmitter and neuropeptide release at the C. elegans neuromuscular junction. J. Physiol. 2007, 585:705-709.
74. Graham M.K., Fairweather I., McGeown J.G. Second messengers mediating mechanical responses to the FaRP GYIRFamide in the fluke Fasciola hepatica. Am. J. Physiol. Regul. Comp. Physiol. 2000, 279:R2089-R2094.
75. Greenwood K., Williams T., Geary T. Nematode neuropeptide receptors and their development as anthelmintic screens. Parasitology 2005, 131:S169-S177.
76. Halton D.W., Shaw C., Maule A.G., Johnston C.F., Fairweather I. Peptidergic messengers: a new perspective of the nervous system of parasitic platyhelminths. J. Parasitol. 1992, 78(2):179-193.
77. Halton D.W., Shaw C., Maule A.G., Smart D. Regulatory peptides in helminth parasites. Adv. Parasitol. 1994, 34:163-227.
78. Halton D.W. Microscopy and the helminth parasite. Micron 2004, 35(5):361-390.
79. Hamamichi S., Rivas R.N., Knight A.L., Cao S., Caldwell K.A., Caldwell G.A. Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. USA 2008, 105:728-733.
80. Hammarlund M., Watanabe S., Schuske K., Jorgensen E.M. CAPS and syntaxin dock dense core vesicles to the plasma membrane in neurons. J. Cell. Biol. 2008, 180:483-491.
81. Harder A., Schmitt-Wrede H.P., Krücken J., Marinovski P., Wunderlich F., Willson J., Amliwala K., Holden-Dye L., Walker R. Cyclooctadepsipeptides - an anthelmintically active class of compounds exhibiting a novel mode of action. Int. J. Antimicrob. Agents 2003, 22:318-331.
82. Hess H.A., Röper J.C., Grill S.W., Koelle M.R. RGS-7 completes a receptor-independent heterotrimeric G protein cycle to asymmetrically regulate mitotic spindle positioning in C. elegans. Cell 2004, 119:209-218.
83. Hiley E., McMullan R., Nurrish S.J. The Galpha12-RGSRhoGEF-RhoA signalling pathway regulates neurotransmitter release in C. elegans. EMBO J. 2006, 25:5884-5895.
84. Ho N.F., Geary T.G., Raub T.J., Barsuhn C.L., Thompson D.P. Biophysical transport properties of the cuticle of Ascaris suum. Mol. Biochem. Parasitol. 1990, 41(2):153-165.
85. Holden-Dye L., Brownlee D.J., Walker R.J. The effects of the peptide KPNFIRFamide (PF4) on the somatic muscle cells of the parasitic nematode Ascaris suum. Br. J. Pharmacol. 1997, 120:379-386.
86. Höller C., Freissmuth M., Nanoff C. G proteins as drug targets. Cell. Mol. Life Sci. 1999, 55:257-270.
87. Hoste H., Torres-Acosta J.F. Non chemical control of helminths in ruminants: adapting solutions for changing worms in a changing world. Vet. Parasitol. 2011, 180:144-154.
88. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., Jacobsen J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118:1311-1321.
89. Hotez P.J., Bethony J.M., Diemert D.J., Pearson M., Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat. Rev. Microbiol. 2010, 8:814-826.
90. Huang G., Allen R., Davis E.L., Baum T.J., Hussey R.S. Engineering broad root-knot resistance in transgenic plants by RNAi silencing of a conserved and essential root-knot nematode parasitism gene. Proc. Natl. Acad. Sci. USA 2006, 103:14301-14306.
91. Huang Q.X., Cheng X.Y., Mao Z.C., Wang Y.S., Zhao L.L., Yan X., Ferris V.R., Xu R.M., Xie B.Y. MicroRNA discovery and analysis of pinewood nematode Bursaphelenchus xylophilus by deep sequencing. PLoS One 2010, 5:e13271.
92. Humphries J.E., Kimber M.J., Barton Y.W., Hsu W., Marks N.J., Greer B., Harriott P., Maule A.G., Day T.A. Structure and bioactivity of neuropeptide F from the human parasites Schistosoma mansoni and Schistosoma japonicum. J. Biol. Chem. 2004, 279:39880-39885.
93. Hussein A.S., Kichenin K., Selkirk M.E. Suppression of secreted acetylcholinesterase expression in Nippostrongylus brasiliensis by RNA interference. Mol. Biochem. Parasitol. 2002, 122(1):91-94.
94. Husson S.J., Schoofs L. Altered neuropeptide profile of Caenorhabditis elegans lacking the chaperone protein 7B2 as analysed by mass spectrometry. FEBS Lett. 2007, 581:4288-4292.
95. Husson S.J., Schoofs L. Processing of neuropeptide precursors in Caenorhabditis elegans. Commun. Agric. Appl. Biol. Sci. 2007, 72:199-203.
96. Husson S.J., Clynen E., Baggerman G., Janssen T., Schoofs L. Defective processing of neuropeptide precursors in Caenorhabditis elegans lacking proprotein convertase 2 (KPC-2/EGL-3): mutant analysis by mass spectrometry. J. Neurochem. 2006, 98:1999-2012.
97. Husson S.J., Janssen T., Baggerman G., Bogert B., Kahn-Kirby A.H., Ashrafi K., Schoofs L. Impaired processing of FLP and NLP peptides in carboxypeptidase E (EGL-21)-deficient Caenorhabditis elegans as analysed by mass spectrometry. J. Neurochem. 2007, 102:246-260.
98. Iltzsch M.H., Bieber D., Vijayasarathy S., Webster P., Zurita M., Ding J., Mansour T.E. Cloning and characterization of a cDNA coding for the alpha-subunit of a stimulatory G protein from Schistosoma mansoni. J. Biol. Chem. 1992, 267:14504-14508.
99. Isaac R.E., Siviter R.J., Stancombe P., Coates D., Shirras A.D. Conserved roles for peptidases in the processing of invertebrate neuropeptides. Biochem. Soc. Trans. 2000, 28:460-464.
100. Ja W.W., Wiser O., Austin R.J., Jan L.Y., Roberts R.W. Turning G proteins on and off using peptide ligands. ACS Chem. Biol. 2006, 1:570-574.
101. Jacoby E., Bouhelal R., Gerspacher M., Seuwen K. The 7 TM G-protein coupled receptor target family. ChemMedChem 2006, 1:761-782.
102. Janssen T., Meelkop E., Lindemans M., Verstraelen K., Husson S.J., Temmerman L., Nachman R.J., Schoofs L. Discovery of a cholecystokinin-gastrin-like signaling system in nematodes. Endocrinology 2008, 149(6):2826-2839.
103. Janssen T., Lindemans M., Meelkop E., Temmerman L., Schoofs L. Coevolution of neuropeptidergic signaling systems: from worm to man. Ann. NY Acad. Sci. 2010, 1200:1-14.
104. Jarecki J.L., Andersen K., Konop C.J., Knickelbine J.J., Vestling M.M., Stretton A.O. Mapping neuropeptide expression by mass spectrometry in single dissected identified neurons from the dorsal ganglion of the nematode Ascaris suum. ACS Chem. Neurosci. 2010, 1:505-519.
105. Jeziorsky M.C., Green K.A., Sommerville J., Cottrell G.A. Cloning and expression of a FMRFamide-gated Na(+) channel from Helisoma trivolvis and comparison with the native neuronal channel. J. Physiol. 2000, 526:13-25.
106. Jiang N., Kolhekar A.S., Jacobs P.S., Mains R.E., Eipper B.A., Taghert P.H. PHM is required for normal developmental transitions and for biosynthesis of secretory peptides in Drosophila. Dev. Biol. 2000, 226:118-136.
107. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Ziperlen P., Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003, 421:231-237.
108. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., Mäser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
109. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 2004, 20:477-481.
110. Kass J., Jacob T.C., Kim P., Kaplan J.M. The EGL-3 proprotein convertase regulates mechanosensory responses of Caenorhabditis elegans. J. Neurosci. 2001, 21:9265-9272.
111. Keating C.D., Kriek N., Daniels M., Ashcroft N.R., Hopper N.A., Siney E.J., Holden-Dye L., Burke J.F. Whole-genome analysis of 60 G protein-coupled receptors in Caenorhabditis elegans by gene knockout with RNAi. Curr. Biol. 2003, 13:1715-1720.
112. Keiser J., Utzinger J. Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes. Trends Parasitol. 2007, 23(11):555-562.
113. Keiser J., Duthaler U., Utzinger J. Update on the diagnosis and treatment of food-borne trematode infections. Curr. Opin. Infect. Dis. 2010, 23(5):513-520.
114. Khayath N., Vicogne J., Ahier A., BenYounes A., Konrad C., Trolet J., Viscogliosi E., Brehm K., Dissous C. Diversification of the insulin receptor family in the helminth parasite Schistosoma mansoni. FEBS. J. 2007, 274:659-676.
115. Kikuchi T., Cotton J.A., Dalzell J.J., Hasegawa K., Kanzaki N., McVeigh P., Takanashi T., Tsai I.J., Assefa S.A., Cock P.J.A., Otto T.D., Hunt M., Reid A.J., Sanchez-Flores A., Tsuchihara K., Yokoi T., Larsson M.C., Miwa J., Maule A.G., Sahashi N., Jones J.T., Berriman M. Genomic insights into the origin of parasitism in the emerging plant pathogen Bursaphelenchus xylophilus. PLoS Pathog. 2011, 7(9):e1002219.
116. Kimber M.J., McKinney S., McMaster S.M., Day T.A., Fleming C.C., Maule A.G. flp Gene disruption in a parasitic nematode reveals motor dysfunction and neuronal sensitivity to RNA interference. FASEB J. 2007, 21(4):1233-1243.
117. Kimber M.J., Sayegh L., El-Shehabi F., Song C., Zamanian M., Woods D.J., Day T.A., Ribeiro P. Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology. Int. J. Parasitol. 2009, 39(11):1215-1222.
118. Kimple A.J., Willard F.S., Giguère P.M., Johnston C.A., Mocanu V., Siderovski D.P. The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Galpha-interaction face. Biochim. Biophys. Acta 2007, 1774(9):1213-1220.
119. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
120. Knowles J., Gromo G. Target selection in drug discovery. Nat. Rev. Drug Discov. 2002, 2:63-69.
121. Koch H.G., Moser M., Müller M. Signal recognition particle-dependent protein targeting, universal to all kingdoms of life. Rev. Physiol. Biochem. Pharmacol. 2003, 146:55-94.
122. Konrad C., Kroner A., Spiliotis M., Zavala-Góngora R., Brehm K. Identification and molecular characterisation of a gene encoding a member of the insulin receptor family in Echinococcus multilocularis. Int. J. Parasitol. 2003, 33(3):301-312.
123. Kovaleva E.S., Yakovlev A.G., Masler E.P., Chitwood D.J. Human proprotein convertase 2 homologue from a plant nematode: cloning, characterization, and comparison with other species. FASEB J. 2002, 16:1099-1101.
124. Kowalska D., Liu J., Appel J.R., Ozawa A., Nefzi A., Mackin R.B., Houghten R.A., Lindberg I. Synthetic small molecule prohormone convertase 2 inhibitors. Mol. Pharmacol. 2009, 75:617-625.
125. Krüger N., Harder A., von Samson-Himmelstjerna G. The putative cyclooctadepsipeptide receptor depsiphilin of the canine hookworm Ancylostoma caninum. Parasitol. Res. 2009, 105(S1):S91-S100.
126. Kubiak T.M., Larsen M.J., Zantello M.R., Bowman J.W., Nulf S.C., Lowery D.E. Functional annotation of the putative orphan Caenorhabditis elegans G-protein-coupled receptor C10C6.2 as a FLP15 peptide receptor. J. Biol. Chem. 2003, 278:42115-42120.
127. Kubiak T.M., Larsen M.J., Bowman J.W., Geary T.G., Lowery D.E. FMRFamide-like peptides encoded on the flp-18 precursor gene activate two isoforms of the orphan Caenorhabditis elegans G-protein-coupled receptor Y58G8A.4 heterologously expressed in mammalian cells. Biopolymers 2008, 90:339-348.
128. Kulathila R., Merkler K.A., Merkler D.J. Enzymatic formation of C-terminal amides. Nat. Prod. Rep. 1999, 16:145-154.
129. Lagerström M.C., Schiöth H.B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 2008, 7:339-357.
130. Lee S.N., Lindberg I. 7B2 prevents unfolding and aggregation of prohormone convertase 2. Endocrinology 2008, 149:4116-4127.
131. Lee B.H., Clothier M.F., Dutton F.E., Nelson S.J., Johnson S.S., Thompson D.P., Geary T.G., Whaley H.D., Haber C.L., Marshall V.P., Kornis G.I., McNally P.L., Ciadella J.I., Martin D.G., Bowman J.W., Baker C.A., Coscarelli E.M., Alexander-Bowman S.J., Davis J.P., Zinser E.W., Wiley V., Lipton M.F., Mauragis M.A. Marcfortine andparaherquamideclass of anthelmintics: discovery of PNU-141962. Curr. Top. Med. Chem. 2002, 2:779-793.
132. Lehner B., Crombie C., Tischler J., Fortunato A., Fraser A.G. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 2006, 38:896-903.
133. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995, 267:1782-1788.
134. Li, C., Kim, K., 2008. Neuropeptides, September 25, 2008. WormBook (Ed.), The C. elegans Research Community, WormBook. Doi: , http://www.wormbook.org.
135. Li C., Kim K. Neuropeptide gene families in Caenorhabditis elegans. Adv. Exp. Med. Biol. 2010, 692:98-137.
136. Li C., Kim K., Nelson L.S. FMRFamide-related neuropeptide gene family in Caenorhabditis elegans. Brain Res. 1999, 848(1-2):26-34.
137. Lin X.G., Ming M., Chen M.R., Niu W.P., Zhang Y.D., Liu B., Jiu Y.M., Yu J.W., Xu T., Wu Z.X. UNC-31/CAPS docks and primes dense core vesicles in C. elegans neurons. Biochem. Biophys. Res. Commun. 2010, 397(3):526-531.
138. Lindemans M., Liu F., Janssen T., Husson S.J., Mertens I., Gäde G., Schoofs L. Adipokinetic hormone signaling through the gonadotropin-releasing hormone receptor modulates egg-laying in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 2009, 106(5):1642-1647.
139. Lingueglia E., Champigny G., Lazdunsky M., Barbry P. Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 1995, 378:730-733.
140. Littleton J.T., Chapman E.R., Kreber R., Garment M.B., Carlson S.D. Temperature-sensitive paralytic mutations demonstrate that synaptic exocytosis requires SNARE complex assembly and disassembly. Neuron 1998, 21:401-413.
141. Lowery, D.E., Geary, T.G., Kubiak, T.M., Larsen, M.J., 2003. G protein-coupled receptor-like receptors and modulators thereof. Pharmacia and Upjohn Company, United States. Patent US 6632621 B1.
142. Maeda I., Kohara Y., Yamamoto M., Sugimoto A. Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr. Biol. 2001, 11:171-176.
143. Mair G.R., Niciu M.J., Stewart M.T., Brennan G., Omar H., Halton D.W., Mains R., Eipper B.A., Maule A.G., Day T.A. A functionally atypical amidating enzyme from the human parasite Schistosoma mansoni. FASEB J. 2004, 18:114-121.
144. Malone E.A., Thomas J.H. A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans. Genetics 1994, 136:879-886.
145. Mansour J.M., Mansour T.E. Identification of GTP-binding proteins in Fasciola hepatica and Schistosoma mansoni by immunoblotting. Mol. Biochem. Parasitol. 1989, 36:11-18.
146. Marks N.J., Maule A.G. Neuropeptides in helminths: occurrence and distribution. Adv. Exp. Med. Biol. 2010, 692:49-77.
147. Marks N.J., Johnson S., Maule A.G., Halton D.W., Shaw C., Geary T.G., Moore S., Thompson D.P. Physiological effects of platyhelminth RFamide peptides on muscle-strip preparations of Fasciola hepatica (Trematoda: Digenea). Parasitology 1996, 113:393-401.
148. Marks N.J., Maule A.G., Halton D.W., Geary T.G., Shaw C., Thompson D.P. Pharmacological effects of nematode FMRFamide-related peptides (FaRPs) on muscle contractility of the trematode, Fasciola hepatica. Parasitology 1997, 114:531-539.
149. Marks N.J., Sangster N.C., Maule A.G., Halton D.W., Thompson D.P., Geary T.G., Shaw C. Structural characterisation and pharmacology of KHEYLRFamide (AF2) and KSAYMRFamide (PF3/AF8) from Haemonchus contortus. Mol. Biochem. Parasitol. 1999, 100:185-194.
150. Martin R.J., Robertson A.P. Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery. Adv. Exp. Med. Biol. 2010, 692:138-154.
151. Martin R.J., Murray I., Robertson A.P., Bjorn H., Sangster N. Anthelmintics and ion-channels: after a puncture, use a patch.Int. J. Parasitol. 1998, 28(6):849-862.
152. Masler E.P. Aminopeptidases in Caenorhabditis elegans and Panagrellus redivivus: detection using peptide and non-peptide substrates. J. Helminthol. 2002, 76:45-52.
153. Masler E.P. In vitro comparison of protease activities in preparations from free-living (Panagrellus redivivus) and plant-parasitic (Meloidogyne incognita) nematodes using FMRFa and FMRFa-like peptides as substrates. J. Helminthol. 2010, 84:425-433.
154. Maule A.G., Shaw C., Halton D.W., Thim L., Johnston C.F., Fairweather I., Buchanan K.D. Neuropeptide F: a novel parasitic flatworm regulatory peptide from Moniezia expansa (Cestoda: Cyclophyllidea). Parasitology 1991, 102:309-316.
155. Maule A.G., Shaw C., Halton D.W., Thim L. GNFFRFamide: A novel FMRFamide-immunoreactive peptide isolated from the sheep tapeworm, Moniezia expansa. Biochem. Biophys. Res. Commun. 1993, 193:1054-1060.
156. Maule A.G., Geary T.G., Bowman J.W., Marks N.J., Blair K.L., Halton D.W., Shaw C., Thompson D.P. Inhibitory effects of nematode FMRFamide-related peptides (FaRPs) on muscle strips from Ascaris suum. Invertebr. Neurosci. 1995, 1:255-265.
157. Maule A.G., Bowman J.W., Thompson D.P., Marks N.J., Friedman A.R., Geary T.G. FMRFamide-related peptides (FaRPs) in nematodes: occurrence and neuromuscular physiology. Parasitology 1996, 113:S119-S135.
158. Maule A.G., Geary T.G., Bowman J.W., Shaw C., Halton D.W., Thompson D.P. The pharmacology of nematode FMRFamide-related peptides. Parasitol. Today 1996, 12(9):351-357.
159. Maule A.G., Mousley A., Marks N.J., Day T.A., Thompson D.P., Geary T.G., Halton D.W. Neuropeptide signaling systems - potential drug targets for parasite and pest control. Curr. Top. Med. Chem. 2002, 2(7):733-758.
160. McCudden C.R., Hains M.D., Kimple R.J., Siderovski D.P., Willard F.S. G-protein signaling: back to the future. Cell Mol. Life Sci. 2005, 62(5):551-577.
161. McGonigle L., Mousley A., Marks N.J., Brennan G.P., Dalton J.P., Spithill T.W., Day T.A., Maule A.G. The silencing of cysteine proteases in Fasciola hepatica newly excysted juveniles using RNA interference. Int. J. Parasitol. 2008, 38(2):149-155.
162. McVeigh P., Kimber M.J., Novozhilova E., Day T.A. Neuropeptide signalling systems in flatworms. Parasitology 2005, 131:S41-S55.
163. McVeigh P., Leech S., Mair G.R., Marks N.J., Geary T.G., Maule A.G. Analysis of FMRFamide-like peptide (FLP) diversity in phylum Nematoda. Int. J. Parasitol. 2005, 35:1043-1060.
164. McVeigh P., Geary T.G., Marks N.J., Maule A.G. The FLP-side of nematodes. Trends Parasitol. 2006, 22:385-396.
165. McVeigh P., Alexander-Bowman S., Veal E., Mousley A., Marks N.J., Maule A.G. Neuropeptide-like protein diversity in phylum Nematoda. Int. J. Parasitol. 2008, 38:1493-1503.
166. McVeigh P., Mair G.R., Atkinson L., Zamanian M., Ladurner P., Novozhilova E., Marks N.J., Day T.A., Maule A.G. Discovery of multiple neuropeptide families in phylum Platyhelminthes. Int. J. Parasitol. 2009, 39:1243-1252.
167. McVeigh P., Mair G.R., Novozhilova E., Day A., Zamanian M., Marks N.J., Kimber M.J., Day T.A., Maule A.G. Schistosome I/Lamides - a new family of bioactive helminth neuropeptides. Int. J. Parasitol. 2011, 41:905-913.
168. Mertens I., Vandingenen A., Meeusen T., Janssen T., Luyten W., Nachman R.J., De Loof A., Schoofs L. Functional characterisation of the putative orphan neuropeptide G-protein coupled receptor C26F1.6 in Caenorhabditis elegans. FEBS. Lett. 2004, 573:55-60.
169. Mertens I., Meeusen T., Janssen T., Nachman R., Schoofs L. Molecular characterization of two G protein-coupled receptor splice variants as FLP2 receptors in Caenorhabditis elegans. Biochem. Biophys. Res. Commun. 2005, 330(3):967-974.
170. Mertens I., Clinckspoor I., Janssen T., Nachman R., Schoofs L. FMRFamide related peptide ligands activate the Caenorhabditis elegans orphan GPCR Y59H11AL 1. Peptides 2006, 27(6):1291-1296.
171. Minic J., Sautel M., Salesse R., Pajot-Augy E. Yeast system as a screening tool for pharmacological assessment of G protein coupled receptors. Curr. Med. Chem. 2005, 12(8):961-969.
172. Moffett C.L., Beckett A.M., Mousley A., Marks N.J., Thompson D.P., Geary T.G., Halton D.W., Maule A.G. The ovijector of Ascaris suum: multiple response types revealed by C. elegans FMRFamide-related peptides. Int. J. Parasitol. 2003, 33:859-876.
173. Mousley A., Marks N.J., Halton D.W., Geary T.G., Thompson D.P., Maule A.G. Arthropod FMRFamide-related peptide modulate muscle activity in helminths. Int. J. Parasitol. 2004, 34:755-768.
174. Mousley A., Maule A.G., Halton D.W., Marks N.J. Inter-phyla studies on neuropeptides: the potential for broad spectrum anthelmintic and/or endectocide discovery. Parasitology 2005, 131:S143-S167.
175. Mousley A., Moffett C.L., Duve H., Thorpe A., Halton D.W., Geary T.G., Thompson D.P., Maule A.G., Marks N.J. Expression and bioactivity of allatostatin-like neuropeptides in helminths. Int. J. Parasitol. 2005, 35:1557-1567.
176. Mousley A., Novozhilova E., Kimber M.J., Day T.A. Neuropeptide physiology in helminths. Adv. Exp. Med. Biol. 2010, 692:78-97.
177. Mühlfeld S., Schmitt-Wrede H.B., Harder A., Wunderlich F. FMRFamide-like neuropeptides as putative ligands of latrophilin-like HC110-R from Haemonchus contortus. Mol. Biochem. Parasitol. 2009, 164:162-164.
178. Muller L., Zhu X., Lindberg I. Mechanism of the facilitation of PC2 maturation by 7B2: involvement in ProPC2 transport and activation but not folding. J. Cell Biol. 1997, 139:625-638.
179. Nana-Sinkam S.P., Croce C.M. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs. IDrugs 2010, 13(12):843-846.
180. Nana-Sinkam S.P., Croce C.M. MicroRNAs as therapeutic targets in cancer. Transl. Res. 2011, 157:216-225.
181. Nanda J.C., Stretton A.O. In situ hybridization of neuropeptide-encoding transcripts afp-1, afp-3, and afp-4 in neurons of the nematode Ascaris suum. J. Comp. Neurol. 2010, 518:896-910.
182. Nollen E.A.A., Garcia S.M., Van Haaften G., Kim S., Chavez A., Morimoto R.I., Plasterk R.H.A. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl Acad. Sci. USA 2004, 101:6403-6408.
183. Novozhilova E., Kimber M.J., Qian H., McVeigh P., Robertson A.P., Zamanian M., Maule A.G., Day T.A. FMRFamide-like peptides enhance voltage-gated calcium currents to elicit muscle contraction in the human parasite Schistosoma mansoni. PLoS Neg. Trop. Dis. 2010, 4:e790.
184. Omar H.H., Humphries J.E., Larsen M.J., Kubiak T.M., Geary T.G., Maule A.G., Kimber M.J., Day T.A. Identification of a platyhelminth neuropeptide receptor. Int. J. Parasitol. 2007, 37:725-733.
185. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there?. Nat. Rev. Drug Discov. 2006, 5:993-996.
186. Pang F.Y., Mason J., Holden-Dye L., Franks C.J., Williams R.G., Walker R.J. The effects of the nematode peptide, KHEYLRFamide (AF2), on the somatic musculature of the parasitic nematode Ascaris suum. Parasitology 1995, 110:353-362.
187. Papaioannou S., Marsden D., Franks C.J., Walker R.J., Holden-Dye L. Role of a FMRFamide-like family of neuropeptides in the pharyngeal nervous system of Caenorhabditis elegans. J. Neurobiol. 2005, 65:304-319.
188. Park S.K., Link C.D., Johnson T.E. Life-span extension by dietary restriction is mediated by NLP-7 signaling and coelomocyte endocytosis in C. elegans. FASEB J. 2010, 24:383-392.
189. Pax R., Bennett J.L., Fetterer R. A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn Schmiedebergs Arch. Pharmacol. 1978, 304(3):309-315.
190. Perrimon N., Lanjuin A., Arnold C., Noll E. Zygotic lethal mutations with maternal effect phenotypes in Drosophila melanogaster. II. Loci on the second and third chromosomes identified by P-element-induced mutations. Genetics 1996, 144:1681-1692.
191. Pierson L., Mousley A., Divine L., Day T.A., Marks N.J., Maule A.G. RNA interference in a cestode reveals specific silencing of selected highly expressed gene transcripts. Int. J. Parasitol. 2010, 40:605-615.
192. Porter M.Y., Koelle M.R. RSBP-1 is a membrane-targeting subunit required by the Galpha(q)-specific but not the Galpha(o)-specific R7 regulator of G protein signaling in Caenorhabditis elegans. Mol. Biol. Cell 2010, 21:232-243.
193. Porter M.Y., Xie K., Pozharski E., Koelle M.R., Martemyanov K.A. A conserved protein interaction interface on the type 5 G protein beta subunit controls proteolytic stability and activity of R7 family regulator of G protein signaling proteins. J. Biol. Chem. 2010, 285:41100-41112.
194. Prigge S.T., Mains R.E., Eipper B.A., Amzel L.M. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol. Life Sci. 2000, 57:1236-1259.
195. Purcell J., Robertson A.P., Thompson D.P., Martin R.J. The time-course of the response to the FMRFamide-related peptide PF4 in Ascaris suum muscle cells indicates direct gating of a chloride ion-channel. Parasitology 2002, 124:649-656.
196. Purcell J., Robertson A.P., Thompson D.P., Martin R.J. PF4, a FMRFamide-related peptide, gates low-conductance Cl(-) channels in Ascaris suum. Eur. J. Pharmacol. 2002, 456:11-17.
197. Rayburn L.Y.M., Gooding H.C., Choksi S.P., Maloney D., Kidd A.R., Siekhaus D.E., Bender M., Bender M. Amontillado, the Drosophila homolog of the prohormone processing protease PC2, is required during embryogenesis and early larval development. Genetics 2003, 163:227-237.
198. Reddien P.W., Bermange A.L., Murfitt K.J., Jennings J.R., Sánchez Alvarado A. Identification of genes needed for regeneration, stem cell function, and tissue homeostasis by systematic gene perturbation in planaria. Dev. Cell 2005, 8:635-649.
199. Rehfeld J.F., Zhu X., Norrbom C., Bundgaard J.R., Johnsen A.H., Nielsen J.E., Vikesaa J., Stein J., Dey A., Steiner D.F., Friis-Hansen L. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17. Biochem. J. 2008, 415(1):35-43.
200. Reinitz C.A., Herfel H.G., Messinger L.A., Stretton A.O. Changes in locomotory behaviour and cAMP produced in Ascaris suum by neuropeptides from Ascarissuum or Caenorhabditis elegans. Mol. Biochem. Parasitol. 2000, 111:185-197.
201. Renden R., Berwin B., Davis W., Ann K., Chin C.T., Kreber R., Ganetzky B., Martin T.F., Broadie K. Drosophila CAPS is an essential gene that regulates dense-core vesicle release and synaptic vesicle fusion. Neuron 2001, 31:421-437.
202. Richmond, J., 2007. Synaptic function (December 7, 2007). In: WormBook (Ed.), The C. elegans Research Community, Wormbook, doi: , http://www.wormbook.org.
203. Robb S.M., Ross E., Sánchez-Alvarado A. SmedGD: the Schmidtea mediterranea genome database. Nucleic Acids Res. 2008, 36:D599-D606.
204. Robertson A.P., Puttachary S., Buxton S.K., Martin R.J. Electrophysiological recording from parasitic nematode muscle. Invertebr. Neurosci. 2008, 8(4):167-175.
205. Rogers C., Reale V., Kim K., Chatwin H., Li C., Evans P., de Bono M. Inhibition of Caenorhabditis elegans social feeding by FMRFamide-related peptide activation of NPR-1. Nat. Neurosci. 2003, 6(11):1178-1185.
206. Rual J.F., Ceron J., Koreth J., Hao T., Nicot A.S., Hirozane-Kishikawa T., Vandenhaute J., Orkin S.H., Hill D.E., van den Heuvel S., Vidal M. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res. 2004, 14:2162-2168.
207. Saeger B., Schmitt-Wrede H.P., Dehnhardt M., Benten W.P., Krücken J., Harder A., Von Samson-Himmelstjerna G., Wiegand H., Wunderlich F. Latrophilin-like receptor from the parasitic nematode Haemonchus contortus as target for the anthelmintic depsipeptide PF1022A. FASEB J. 2001, 15:1332-1334.
208. 2) in the nematode Ascaris suum. Biochem. Soc. Trans. 1994, 22:293S.
209. Sajid M., Isaac R.E. Identification and properties of a neuropeptide-degrading endopeptidase (neprilysin) of Ascaris suum muscle. Parasitology 1995, 111:599-608.
210. 2) in the nematode, Ascaris suum, by aminopeptidase, endopeptidase and deamidase enzymes. Mol. Biochem. Parasitol. 1996, 75:159-168.
211. Sajid M., Isaac R.E., Harrow I.D. Purification and properties of a membrane aminopeptidase from Ascaris suum muscle that degrades neuropeptides AF1 and AF2. Mol. Biochem. Parasitol. 1997, 89:225-234.
212. Sayed A.A., Simeonov A., Thomas C.J., Inglese J., Austin C.P., Williams D.L. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nat. Med. 2008, 14(4):407-412.
213. Schaefer M., Petronczki M., Dorner D., Forte M., Knoblich J.A. Heterotrimeric G proteins direct two modes of asymmetric cell division in the Drosophila nervous system. Cell 2001, 107:183-194.
214. Seidah N.G. What lies ahead for the proprotein convertases?. Ann. NY Acad. Sci. 2011, 1220:149-161.
215. Settle S.H., Green M.M., Burtis K.C. The silver gene of Drosophilamelanogaster encodes multiple carboxypeptidases similar to mammalian prohormone-processing enzymes. Proc. Natl. Acad. Sci. USA 1995, 92:9470-9474.
216. Sheehy B.A., Ho N.F., Burton P.S., Day J.S., Geary T.G., Thompson D.P. Transport of model peptides across Ascaris suum cuticle. Mol. Biochem. Parasitol. 2000, 105(1):39-49.
217. Sieburth D., Ch'ng Q., Dybbs M., Tavazoie M., Kennedy S., Wang D., Dupuy D., Rual J.F., Hill D.E., Vidal M., Ruvkun G., Kaplan J.M. Systematic analysis of genes required for synapse structure and function. Nature 2005, 436:510-517.
218. Sieburth D., Madison J.M., Kaplan J.M. PKC-1 regulates secretion of neuropeptides. Nat. Neurosci. 2007, 10:49-57.
219. Simmer F., Moorman C., van der Linden A.M., Kuijk E., van den Berghe P.V.E., Kamath F.S., Fraser A.G., Ahringer J., Plasterk R.H.A. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol. 2003, 1:e12.
220. Sjögren B., Blazer L.L., Neubig R.R. Regulators of G protein signaling proteins as targets for drug discovery. Prog. Mol. Biol. Transl. Sci. 2010, 91:81-119.
221. Skelly P.J., Da'dara A., Harn D.A. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int. J. Parasitol. 2003, 33(4):363-369.
222. Smrcka A.V., Lehmann D.M., Dessal A.L. G protein betagamma subunits as targets for small molecule therapeutic development. Comb. Chem. High Throughput Screen. 2008, 11:382-395.
223. Sonnichsen B., Koski L.B., Walsh A., Marschall P., Neumann B., Brehm M., Alleaume A.M., Artelt J., Bettencourt P., Cassin E., Hewitson M., Holz C., Khan M., Lazik S., Martin C., Nitzsche B., Ruer M., Stamford J., Winzi M., Heinkel R., Roder M., Finell J., Hantsch H., Jones S.J., Jones M., Piano F., Gunsalus K.C., Oegema K., Gonczy P., Coulson A., Hyman A.A., Echeverri C.J. Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 2005, 434:462-469.
224. Spanier B., Stürzenbaum S.R., Holden-Dye L.M., Baumeister R. Caenorhabditis elegans neprilysin NEP-1: an effector of locomotion and pharyngeal pumping. Mol. Biol. 2005, 352(2):429-437.
225. Speese S., Petrie M., Schuske K., Ailion M., Ann K., Iwasaki K., Jorgensen E.M., Martin T.F. UNC-31 (CAPS) is required fordense-core vesiclebut not synaptic vesicle exocytosis in Caenorhabditis elegans. J. Neurosci. 2007, 27:6150-6162.
226. Stefanić S.S., Dvořák J., Horn M., Braschi S., Sojka D., Ruelas D.S., Suzuki B., Lim K.C., Hopkins S.D., McKerrow J.H., Caffrey C.R. RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl. Trop. Dis. 2010, 4:e850.
227. Sutherland I.A., Leathwick D.M. Anthelmintic resistance in nematode parasites of cattle: a global issue?. Trends Parasitol. 2011, 37:176-181.
228. Taman A., Ribeiro P. Investigation of a dopamine receptor in Schistosoma mansoni: functional studies and immunolocalization. Mol. Biochem. Parasitol. 2009, 168(1):24-33.
229. Taman A., Ribeiro P. Glutamate-mediated signaling in Schistosoma mansoni: a novel glutamate receptor is expressed in neurons and the female reproductive tract. Mol. Biochem. Parasitol. 2011, 176(1):42-50.
230. Taylor C.M., Fischer K., Abubucker A., Wang Z., Martin J., Jiang D., Magliano M., Rosso M.N., Li B.W., Fischer P.U., Mitreva M. Targeting protein-protein interactions for parasite control. PLoS One 2011, 6:e18381.
231. Thompson D.P., Klein R.D., Geary T.G. Prospects for rational approaches to anthelmintic discovery. Parasitology 1996, 113:S217-S238.
232. Thompson D.P., Davis J.P., Larsen M.J., Coscarelli E.M., Zinser E.W., Bowman J.W., Alexander-Bowman S.J., Marks N.J., Geary T.G. Effects of KHEYLRFamide and KNEFIRFamide on cyclic adenosine monophosphate levels in Ascaris suum somatic muscle. Int. J. Parasitol. 2003, 33:199-208.
233. Trent C., Tsuing N., Horvitz H.R. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 1983, 104:619-647.
234. Trim N., Brooman J.E., Holden-Dye L., Walker R.J. The role of cAMP in the actions of the peptide AF3 in the parasitic nematodes Ascaris suum and Ascaridia galli. Mol. Biochem. Parasitol. 1998, 93:263-271.
235. Urwin P.E., Lilley C.J., Atkinson H.J. Ingestion of double-stranded RNA by pre-parasitic juvenile cyst nematodes leads to RNA interference. Mol. Plant Microbe Interact. 2002, 15:747-752.
236. Van Horssen A.M., van den Hurk W.H., Bailyes E.M., Hutton J.C., Martens G.J., Lindberg I. Identification of the region within the neuroendocrine polypeptide 7B2 responsible for the inhibition of prohormone convertase PC2. J. Biol. Chem. 1995, 270:14292-14296.
237. Veenstra J.L. Mono- and dibasic proteolytic cleavage sites in insect neuroendocrine precursors. Arch. Insect Biochem. Physiol. 2000, 43:49-63.
238. Vicogne J., Dissous C. Schistosoma mansoni receptor tyrosine kinases: towards new therapeutic targets. J. Soc. Biol. 2003, 197(4):367-373.
239. Voogd T.E., Vansterkenburg E.L.M., Wilting J., Janssen L.H.M. Recent research on the biological activity of suramin. Pharmacol. Rev. 1993, 45:177-203.
240. Wang H., Xu H., Wu L.J., Kim S.S., Chen T., Koga K., Descalzi G., Gong B., Vadakkan K.I., Zhang X., Kaang B.K., Zhuo M. Identification of an adenylyl cyclaseinhibitor for treating neuropathic and inflammatory pain. Sci. Transl. Med. 2011, 3:65ra3.
241. Welz C., Harder A., Schnieder T., Hoglund J., von Samson-Himmelstjerna G. Putative G protein-coupled receptors in parasitic nematodes-potential targets for the new anthelmintic class cyclooctadepsipeptides?. Parasitol. Res. 2005, 97:S22-S32.
242. Williamson S.M., Robertson A.P., Brown L., Williams T., Woods D.J., Martin R.J., Sattelle D.B., Wolstenholme A.J. The nicotinic acetylcholine receptors of the parasitic nematode Ascaris suum: formation of two distinct drug targets by varying the relative expression levels of two subunits. PLoS Pathog. 2009, 5(7):e1000517.
243. Wise A., Gearing K., Rees S. Target validation of G protein-coupled receptors. Drug Discov. Today 2002, 7:235-246.
244. Wolfgang W.J., Hoskote A., Roberts I.J.H., Jackson S., Forte M. Genetic analysis of the Drosophila Gs gene. Genetics 2001, 158:1189-1201.
245. Wolstenholme A.J., Rogers A.T. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 2005, 131:S85-S95.
246. Woods D., Butler C., Williams T., Greenwood K. Receptor-based discovery strategies for insecticides and parasiticides: a review. Adv. Exp. Med. Biol. 2010, 692:1-9.
247. Yadav B.C., Veluthambi K., Subramaniam K. Host-generated double stranded RNA induces RNAi in plant-parasitic nematodes and protects the host from infection. Mol. Biochem. Parasitol. 2006, 148:219-222.
248. Yau D.M., Yokoyama N., Goshima Y., Siddiqui Z.K., Siddiqui S.S., Kozasa T. Identification and molecular characterization of the G alpha12-Rho guanine nucleotide exchange factor pathway in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 2003, 100:14748-14753.
249. Yew J.Y., Kutz K.K., Dikler S., Messinger L., Li L., Stretton A.O. Mass spectrometric map of neuropeptide expression in Ascaris suum. J. Comp. Neurol. 2005, 488(4):396-413.
250. You H., Zhang W., Jones M.K., Gobert G.N., Mulvenna J., Rees G., Spanevello M., Blair D., Duke M., Brehm K., McManus D.P. Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS One 2010, 5:e9868.
251. You H., Gobert G.N., Jones M.K., Zhang W., McManus D.P. Signalling pathways and the host-parasite relationship: putative targets for control interventions against schistosomiasis: signalling pathways and future anti-schistosome therapies. Bioessays 2011, 33:203-214.
252. Zahn T.R., Angleson J.K., MacMorris M.A., Domke E., Hutton J.F., Scwartz C., Hutton J.C. Dense core vesicle dynamics in Caenorhabditis elegans neurons and the role of kinesin UNC-104. Traffic 2004, 5:544-559.
253. Zamanian, M., Kimber, M.J., McVeigh, P., Carlson, A., Maule, A.G., Day, T.A., in press. The repertoire of G protein-coupled receptors in the human parasite Schistosoma mansoni and the model organism Schmidtea mediterranea. BMC Genomics.
254. Zhang X., Bao L., Ma G.Q. Sorting of neuropeptides and neuropeptide receptors into secretory pathways. Prog. Neurobiol. 2010, 90:276-283.
255. Zinser E.W., Wolf M.L., Alexander-Bowman S.J., Thomas E.M., Davis J.P., Groppi V.E., Lee B.H., Thompson D.P., Geary T.G. Anthelmintic paraherquamides are cholinergic antagonists in gastrointestinal nematodes and mammals. J. Vet. Pharmacol. Ther. 2002, 25:241-250.
256. Zugasti O., Rajan J., Kuwabara P.E. The function and expansion of the Patched- and Hedgehog-related homologs in C. elegans. Genome Res. 2005, 15:1402-1410.